Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Usefulness of Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) With Abdominal Sonography or Computed Tomography for Early Detection of Hepatocellular Carcinoma

NCT04414956 is registered in ClinicalTrials.gov with Korea University as lead sponsor.

NCT NCT04414956
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04414956 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Usefulness of Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) With Abdominal Sonography or Computed Tomography for Early Detection of Hepatocellular Carcinoma
Lead sponsor
Korea University
Phase
Not applicable
Overall status
Unknown status
Start date
July 1, 2016
Completion date
February 28, 2026
Enrollment
1,418 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, liver cirrhosis, surveillance